VOYA Investment Management
JANX icon

VOYA Investment Management’s Janux Therapeutics JANX Stock Holding History

VOYA Investment Management’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,638
Closed -$246K – 2546
2025
Q2 		$246K Sell
10,638
-11,376
-52% -$300K ﹤0.01% 2242
2025
Q1 		$594K Sell
22,014
-22,240
-50% -$838K ﹤0.01% 1791
2024
Q4 		$2.37M Sell
44,254
-25,547
-37% -$1.35M ﹤0.01% 1240
2024
Q3 		$3.17M Buy
69,801
+9,223
+15% +$401K ﹤0.01% 1185
2024
Q2 		$2.54M Buy
60,578
+19,925
+49% +$936K ﹤0.01% 1243
2024
Q1 		$1.53M Buy
+40,653
New +$885K ﹤0.01% 1449

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VOYA Investment Management's JANX Position: Q3 2025 in Review

VOYA Investment Management sold out of Janux Therapeutics (JANX) in Q3 2025, closing a stake of 10,638 shares — an estimated $246K sold.

VOYA Investment Management first reported a position in JANX in Q1 2024 and held it in 6 quarters. The position peaked at $3.17M in Q3 2024. 174 funds tracked by Wall St. Rank hold JANX as of Q3 2025.

  • VOYA Investment Management reported no remaining Janux Therapeutics position as of Q3 2025 after selling out during the quarter.
  • VOYA Investment Management sold 10,638 Janux Therapeutics shares in Q3 2025, an estimated $246K.
  • VOYA Investment Management first reported a position in Janux Therapeutics in Q1 2024 and held it in 6 quarters.
  • VOYA Investment Management's Janux Therapeutics position peaked at $3.17M in Q3 2024.
  • 174 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2025.

Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.